z-logo
Premium
The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study
Author(s) -
Hanagasi Hasmet A.
Publication year - 2015
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.26235
Subject(s) - rasagiline , neurology , dementia , behavioral neurology , medicine , placebo , double blind , family medicine , psychology , psychiatry , parkinson's disease , alternative medicine , disease , pathology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here